934 results match your criteria: "
Beijing Tuberculosis and Thoracic Tumor Research Institute[Affiliation]"

Prognostic analysis of destroyed-lung patients with preoperative massive hemoptysis: a 20-year retrospective study.

BMC Pulm Med

August 2024

Department of Cellular and Molecular Biology, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, No 9, Bei guan Street, Tong Zhou District, Beijing, 101149, P. R. China.

Background: Surgery is the main treatment option for destroyed-lung (DL) patients with life-threatening massive hemoptysis. However, short-term and long-term surgical safety and efficacy are unclear, prompting this study.

Methods: Data from 124 DL patients undergoing surgery between November 2001 and January 2022 at Beijing Chest Hospital were retrospectively analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • - Tuberculosis (TB) is a significant global health issue, necessitating research for new anti-TB drugs to aid in elimination efforts.
  • - A new class of anti-TB agents was identified, with two compounds showing excellent activity against TB bacteria and low toxicity.
  • - These compounds also demonstrated good metabolic stability and oral bioavailability, exhibiting protective effects in zebrafish studies, making them strong candidates for further research.
View Article and Find Full Text PDF

CRISPR Screening and Comparative LC-MS Analysis Identify Genes Mediating Efficacy of Delamanid and Pretomanid against Mycobacterium tuberculosis.

Adv Sci (Weinh)

October 2024

NHC Key Laboratory of Systems Biology of Pathogens, State Key Laboratory of Respiratory Health and Multimorbidity, National Institute of Pathogen Biology and Center for Tuberculosis Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, P. R. China.

Tuberculosis (TB), the leading cause of death from bacterial infections worldwide, results from infection with Mycobacterium tuberculosis (Mtb). The antitubercular agents delamanid (DLM) and pretomanid (PMD) are nitroimidazole prodrugs that require activation by an enzyme intrinsic to Mtb; however, the mechanism(s) of action and the associated metabolic pathways are largely unclear. Profiling of the chemical-genetic interactions of PMD and DLM in Mtb using combined CRISPR screening reveals that the mutation of rv2073c increases susceptibility of Mtb to these nitroimidazole drugs both in vitro and in infected mice, whereas mutation of rv0078 increases drug resistance.

View Article and Find Full Text PDF

Specific Cytokines Analysis Incorporating Latency-Associated Antigens Differentiates Infection Status: An Exploratory Study.

Infect Drug Resist

August 2024

Division of Infectious Diseases, Department of Internal Medicine, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Introduction: Current immunologic methods cannot distinguish (Mtb) infection statuses, especially to discriminate active tuberculosis (ATB) from latent tuberculosis infection (LTBI). This study explored the potential of latency-associated antigens (Rv1733cSLP and Rv2028c) and multifactorial cytokine detection to distinguish tuberculosis infection states.

Methods: ATB patients (20), LTBI healthcare workers (25), fever patients (11), and healthy controls (10) were enrolled.

View Article and Find Full Text PDF

Objectives: The roles of magnetic resonance imaging (MRI) -based radiomics approach and deep learning approach in cervical adenocarcinoma (AC) have not been explored. Herein, we aim to develop prognosis-predictive models based on MRI-radiomics and clinical features for AC patients.

Methods: Clinical and pathological information from one hundred and ninety-seven patients with cervical AC was collected and analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • - This study examined the effectiveness of bedaquiline and delamanid for treating multidrug-resistant tracheobronchial tuberculosis, analyzing data from 101 patients over four years and comparing treatment outcomes across three groups: bedaquiline, delamanid, and a control group.
  • - Both bedaquiline and delamanid resulted in higher rates of culture conversion and shorter median times to culture conversion (2 weeks) compared to the control group (12 weeks), though overall treatment success rates were not significantly different.
  • - Delamanid showed more effective improvement in airway stenosis than bedaquiline, indicating that while both drugs may speed up early treatment outcomes, delamanid might be better for addressing airway narrowing issues.
View Article and Find Full Text PDF

Clofazimine inhibits innate immunity against by NF-κB.

mSphere

August 2024

Department of Pharmacology, Beijing Chest Hospital, Capital Medical University, Beijing, China.

Unlabelled: Tuberculosis (TB) remains one of the infectious diseases with high incidence and high mortality. About a quarter of the population has been latently infected with . At present, the available TB treatment strategies have the disadvantages of too long treatment duration and serious adverse reactions.

View Article and Find Full Text PDF

Variations in Quinolinic Acid Levels in Tuberculosis Patients with Diabetes Comorbidity: A Pilot Prospective Cohort Study.

Infect Drug Resist

July 2024

Department of Pharmacology, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.

Objective: We aimed to investigate dysregulated metabolic pathways and identify diagnostic and therapeutic targets in patients with tuberculosis-diabetes (TB-DM).

Methods: In our prospective cohort study, plasma samples were collected from healthy individuals, diabetic (DM) patients, untreated TB-only (TB-0)/TB-DM patients (TB-DM-0), and cured TB (TB-6)/TB-DM patients (TB-DM-6) to measure the levels of amino acids, fatty acids, and other metabolites in plasma using high-throughput targeted quantification methods.

Results: Significantly different biological processes and biomarkers were identified in DM, TB-DM-0, and TB-DM-6 patients.

View Article and Find Full Text PDF

DNA nanotechnology combines structural design with therapeutic functions via programmable DNA motifs, but faces challenges in drug loading capacity. Herein a pore-engineering strategy is reported to develop a highly porous, universal DNA nano-vehicle through coordination self-assembly, cryo-engineering, and supramolecular chemistry, adapting to diverse cargo loading with desired theranostic agents. Thus, the complex synthesis and compatibility challenges typically associated with switching between different drug carriers are avoided.

View Article and Find Full Text PDF

LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis.

EMBO Mol Med

August 2024

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.

Chronic infections, including Mycobacterium tuberculosis (Mtb)-caused tuberculosis (TB), can induce host immune exhaustion. However, the key checkpoint molecules involved in this process and the underlying regulatory mechanisms remain largely undefined, which impede the application of checkpoint-based immunotherapy in infectious diseases. Here, through adopting time-of-flight mass cytometry and transcriptional profiling to systematically analyze natural killer (NK) cell surface receptors, we identify leukocyte immunoglobulin like receptor B1 (LILRB1) as a critical checkpoint receptor that defines a TB-associated cell subset (LILRB1 NK cells) and drives NK cell exhaustion in TB.

View Article and Find Full Text PDF

Real-world data on ALK rearrangement test in Chinese advanced non-small cell lung cancer (RATICAL): a nationwide multicenter retrospective study.

Cancer Commun (Lond)

September 2024

Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.

Background: Anaplastic lymphoma kinase (ALK) test in advanced non-small cell lung cancer (NSCLC) can help physicians provide target therapies for patients harboring ALK gene rearrangement. This study aimed to investigate the real-world test patterns and positive rates of ALK gene rearrangements in advanced NSCLC.

Methods: In this real-world study (ChiCTR2000030266), patients with advanced NSCLC who underwent an ALK rearrangement test in 30 medical centers in China between October 1, 2018 and December 31, 2019 were retrospectively analyzed.

View Article and Find Full Text PDF

Corrigendum to "Genomic investigation of bone tuberculosis highlighted the role of subclinical pulmonary tuberculosis in transmission" [Tuberculosis (2024) 102534].

Tuberculosis (Edinb)

September 2024

Beijing Chest Hospital, Capital Medical University, Beijing, China; Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China; Beijing Key Laboratory for Drug-resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing, China; Beijing Municipal Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing, China. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • Research on gastrointestinal mucosal adenocarcinoma (GMA) has been limited, and this study aims to understand its prognosis and develop a predictive model for post-operative survival.
  • Using data from the Surveillance, Epidemiology, and End Results database, the study analyzed various clinical factors affecting GMA outcomes through a three-part cohort approach (discovery, validation, and test groups).
  • The resulting predictive model demonstrated decent accuracy (AUC ranging from 0.7244 to 0.7433) and highlighted that factors like regional node examination and chemotherapy significantly improve patient survival, especially for challenging cases like mucinous gastric adenocarcinoma.
View Article and Find Full Text PDF
Article Synopsis
  • The FURLONG study compared the effectiveness of furmonertinib and gefitinib as first-line treatments for patients with EGFR mutation-positive non-small cell lung cancer (NSCLC), with a focus on patient-reported outcomes (PROs).
  • In this Phase 3 trial, 357 patients were randomly assigned to receive either furmonertinib or gefitinib, and their quality of life was measured using specific questionnaires.
  • Results showed furmonertinib had better scores in various health aspects like physical functioning and reduced symptoms (e.g., nausea, appetite loss) compared to gefitinib, though some statistical improvements did not reach the level of clinical significance.
View Article and Find Full Text PDF

Machine Learning Approach in Dosage Individualization of Isoniazid for Tuberculosis.

Clin Pharmacokinet

July 2024

Department of Pharmacy, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

Introduction: Isoniazid is a first-line antituberculosis agent with high variability, which would profit from individualized dosing. Concentrations of isoniazid at 2 h (C), as an indicator of safety and efficacy, are important for optimizing therapy.

Objective: The objective of this study was to establish machine learning (ML) models to predict the C, that can be used for establishing an individualized dosing regimen in clinical practice.

View Article and Find Full Text PDF

An optimum safety excision margin (EM) delineated by precise demarcation of field cancerization along with reliable biomarkers that enable predicting and timely evaluating patients' response to immunotherapy significantly impact effective management of melanoma. In this study, optimized biphasic "immunofluorescence staining integrated with fluorescence insitu hybridization" (iFISH) was conducted along the diagnosis-metastasis-treatment-cellular MRD axis to longitudinally co-detect a full spectrum of intact CD31 aneuploid tumor cells (TCs), CD31 aneuploid tumor endothelial cells (TECs), viable and necrotic circulating TCs (CTCs) and circulating TECs (CTECs) expressing PD-L1, Ki67, p16 and Vimentin in unsliced specimens of the resected primary tumor, EM, dissected sentinel lymph nodes (SLNs) and peripheral blood in an early-stage melanoma patient. Numerous PD-L1 aneuploid TCs and TECs were detected at the conventional safety EM (2 cm), quantitatively indicating the existence of a field cancerized EM for the first time.

View Article and Find Full Text PDF

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Is Associated With Recurrence and Survival of Resectable Non-Small Cell Lung Cancer (NSCLC): A Retrospective Study.

J Surg Res

September 2024

Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Department of Medical Oncology, Capital Medical University, Beijing, China. Electronic address:

Introduction: Curative lung resection remains the key therapeutic strategy for early-stage non-small cell lung cancer (NSCLC). However, a proportion of patients still experience variable outcomes and eventually develop recurrence or die from their disease. Proprotein convertase subtilisin/kexin type 9 (PCSK9) has been identified as a deleterious factor that inhibits tumor cells apoptosis and leads to reduction of lymphocyte infiltration.

View Article and Find Full Text PDF

Inhibition of M. tuberculosis and human ATP synthase by BDQ and TBAJ-587.

Nature

July 2024

State Key Laboratory of Medicinal Chemical Biology and College of Life Sciences, Nankai University, Tianjin, China.

Bedaquiline (BDQ), a first-in-class diarylquinoline anti-tuberculosis drug, and its analogue, TBAJ-587, prevent the growth and proliferation of Mycobacterium tuberculosis by inhibiting ATP synthase. However, BDQ also inhibits human ATP synthase. At present, how these compounds interact with either M.

View Article and Find Full Text PDF

To explore the characteristics of adverse drug reactions during the 24-week therapy with delamanid-containing regimen for patients with multidrug-resistant and rifampicin-resistant pulmonary tuberculosis (MDR/RR-PTB). The prospective multicenter study was conducted from June 2020 to June 2023. A total of 608 eligible patients with MDR/RR-PTB were enrolled in 26 tuberculosis medical institutions in China including 364 males and 79 females, aged 39.

View Article and Find Full Text PDF

Background: The current prophylactic tuberculosis vaccine Bacille Calmette-Guérin (BCG), was derived in the 1920s, but the humoral immune responses induced by BCG vaccination have not been fully elucidated to date. In this study, our aim was to reveal the profiles of antibody responses induced by BCG vaccination in adults and identify the potential biomarkers for evaluating the BCG vaccination response.

Methods: Proteome microarrays were performed to reveal the serum profiles of antibody responses induced by BCG vaccination in adults.

View Article and Find Full Text PDF

This study aims to explore the interaction of glycemic control and statin use on the treatment outcomes of pulmonary tuberculosis-diabetes comorbidity (PTB-DM) patients. A nested case-control study was conducted in a tuberculosis patients' cohort. We defined cases as patients who experienced unfavorable outcomes.

View Article and Find Full Text PDF

Background: Tuberculosis (TB) stands as the second most prevalent infectious agent-related cause of death worldwide in 2022, trailing only COVID-19. With 1.13 million reported deaths, this figure is more than half of the mortality associated with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), which accounted for 0.

View Article and Find Full Text PDF

The levels of soluble CD137 are increased in tuberculosis patients and associated with disease severity and prognosis.

Eur J Immunol

August 2024

Department of Clinical Laboratory, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.

Tuberculosis (TB) was the leading cause of death from a single infectious agent before the coronavirus pandemic. Therefore, it is important to search for severity biomarkers and devise appropriate therapies. A total of 139 pulmonary TB (PTB) patients and 80 healthy controls (HCs) were recruited for plasma soluble CD137 (sCD137) detection through ELISA.

View Article and Find Full Text PDF

Quantitative analysis of the lysine acetylome reveals the role of SIRT3-mediated HSP60 deacetylation in suppressing intracellular survival.

Microbiol Spectr

August 2024

Laboratory of Molecular Biology, Beijing Key Laboratory for Drug Resistance Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China.

Article Synopsis
  • This study looks at how a process called acetylation affects proteins in cells during tuberculosis infection and how it relates to the immune response.
  • The researchers identified many specific acetylated proteins in cells that were and weren't infected, revealing changes in how these cells behave.
  • They found that a protein called HSP60, when changed by another protein named SIRT3, helps increase cell death in infected macrophages, suggesting potential ways to help the immune system fight tuberculosis.
View Article and Find Full Text PDF

Analysis of clinical characteristics of different types of lung function impaiement in TDL patients.

BMC Pulm Med

June 2024

Department of Cellular and Molecular Biology, Beijing Chest Hospital, Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, P. R. China.

Aim: The clinical characteristics associated with pulmonary function decline in patients with Tuberculosis-destroyed lung (TDL) remain uncertain. We categorize them based on the pattern of pulmonary function impairment, distinguishing between restrictive spirometric pattern (RSP) and obstructive spirometric pattern (OSP). We aim to compare the severity of these patterns with the clinical characteristics of TDL patients and analyze their correlation.

View Article and Find Full Text PDF